山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (3): 29-33.doi: 10.6040/j.issn.1671-7554.0.2018.101
• • 上一篇
徐智慧,魏海彬
XU Zhihui, WEI Haibin
摘要: 骶神经调节(SNM)技术是一种通过人工植入的“起搏器”发出短脉冲刺激电流信号连续作用特定的骶神经,以调节膀胱、尿道括约肌及盆底等骶神经支配的下游效应器官的微创技术。SNM技术分体验阶段与长期刺激器植入阶段,疗效可靠,操作简便易学,在难治性膀胱功能障碍中有着广阔的应用前景。对于患者来说,SNM技术具有微创有效、疗效持久及耐受性佳等优点,深受顽固性排尿功能障碍患者的青睐。简述SNM技术的作用原理及优势,总结近年SNM技术在排尿功能障碍治疗领域的应用,分析其未来的发展方向及应用前景。
中图分类号:
[1] 张德清,朱耀丰,孟辉,等.膀胱内灌注透明质酸钠治疗非细菌性膀胱炎的临床观察[J].山东大学学报(医学版), 2013, 51(1): 79-82. ZHANG Deqing, ZHU Yaofeng, MENG Hui, et al. Clinical observation on intravesical instillation of sodium hyaluronate for treatment of non-bacterial cystitis[J]. Journal of Shandong University(Health Science), 2013, 51(1): 79-82. [2] Madersbacher H. Conservative therapy of neurogenic disorders of micturition[J]. Urologe A, 1999, 38(1): 24-29. [3] Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future[J]. Urology, 1982, 20(6): 614-619. [4] Tanagho EA. Neural stimulation for bladder control[J]. Semin Neurol, 1988, 8(2): 170-173. [5] 卫中庆.排尿功能障碍治疗的新亮点——骶神经调节(排尿起博器)治疗技术[J]. 中华医学信息导报, 2005, 20(13): 15. [6] Schmidt RA. Applications of neurostimulation in urology[J]. Neurourology and Urodynamics, 1988, 7(6): 585-592. [7] Steele SS. Sacral nerve stimulation: 50 years in the making[J]. Can UrolAssoc J, 2012, 6(4): 231-232. [8] 陈国庆, 廖利民. 骶神经调节在神经源性膀胱中的应用[J]. 临床外科杂志, 2016, 24(2): 102-104. [9] Simpson JA, Peacock J, Maxwell-Armstrong C. Use of a gentamicin-impregnated collagen sheet(Collatamp(®))following implantation of a sacral nerve stimulator for faecal incontinence[J]. Colorectal Dis, 2012, 14(4): e200-e202. doi: 10.1111/j.1463-1318.2011.02886.x. [10] Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention[J]. Urology, 2000, 56(6): 87-91. [11] van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study[J]. J Urol, 2007, 178(5): 2029-2034. [12] Hoda MR, Fornara P. Sacral neuromodulation in urology. The emperors new clothes or effective high-tech medicine?[J]. Urologe A, 2010, 49(10): 1254-1259. [13] 李延伟,李一冬,文建国.骶神经调节治疗非梗阻性尿潴留的研究进展[J].中华临床医师杂志(电子版), 2016, 10(23): 3598-3601. LI Yanwei, LI Yidong, WEN Jianguo. Advances in sacral neuromodulation for the treatment of nonobstruction urinary retention[J]. Chin J Clinicians(Electronic Edition), 2016, 10(23): 3598-3601. [14] Cardarelli S, DElia C, Cerruto MA, et al. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project[J]. Urologia, 2012, 79(2): 90-96. [15] Dyer AJ, Twiss CO. Painful bladder syndrome: an update and review of current management strategies[J]. Curr Urol Rep, 2014, 15(2): 384. [16] Elbadawi AE, Light JK. Distinctive ultrastructural pathology of nonulcerativeinterstitial cystitis[J]. Urol Int, 1996, 56(3): 137-162. [17] Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis[J]. Urology, 2007, 69(4): 24-33. [18] 张鹏,吴栗洋.骶神经调节治疗慢性间质性膀胱炎/盆腔疼痛综合征[J].现代泌尿外科杂志, 2016, 21(8): 573-576. ZHANG Peng, WU Liyang. Treating chronic interstitial cystitis/pelvic pain syndrome with sacral neuromodulation[J]. Journal of Modern Urology, 2016, 21(8): 573-576. [19] Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures[J]. J Urol, 2010, 183(1): 173-176. [20] Gajewski JB, Alzahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre[J]. BJU Int, 2011, 107(8): 1258-1264. [21] Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis[J]. Eur Urol, 2010, 58(6): 865-874. [22] Chen G, Liao L. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease[J]. Spinal Cord, 2014. doi: 10.1038/sc.2014.157. [23] 徐智慧,吕佳,王帅,等.骶神经调节治疗慢性非梗阻性尿潴留的临床观察[C].浙江省泌尿外科学男科学学术年会, 2015. [24] Lombardi G, Nelli F, Mencarini M, et al. Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury[J]. Spinal Cord, 2011, 49(5): 629-636. [25] 顾寅珺,吕婷婷,方伟林,等.3D打印技术在骶神经调控术中精准穿刺的应用评估研究[J].临床泌尿外科杂志, 2016, 31(12): 1057-1059. GU Yinjun, LÜ Tingting, FANG Weilin, et al. 3D printing in the evaluation of sacral neuromodulation[J]. Journal of Modern Urology, 2016, 31(12): 1057-1059. [26] Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis[J]. World J Urol, 2012, 30(1): 123-128. |
[1] | 马翔,赵飞燕. 。卵子冷冻保存现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 19-23. |
[2] | 史本康,陈守臻,曲思凤,王勇,刘磊. 临床常见快速进展前列腺癌临床特点及研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 110-116. |
[3] | 王沂峰,何丽清. 外阴癌腹股沟淋巴结手术的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 103-109,116. |
[4] | 王传新. 肿瘤液体活检[J]. 山东大学学报 (医学版), 2021, 59(9): 64-71. |
[5] | 孙庆杰,张怡莎,管尚慧,凤志慧. 丙戊酸对134例放疗神经胶质瘤患者预后生存和肿瘤复发的影响[J]. 山东大学学报 (医学版), 2021, 59(8): 80-85. |
[6] | 黄蕾,叶子雯,李湉湉. 环境健康风险感知研究进展[J]. 山东大学学报 (医学版), 2021, 59(12): 6-12. |
[7] | 陈安静,张训. 靶向小类泛素化修饰的胶质瘤治疗新策略[J]. 山东大学学报 (医学版), 2020, 1(8): 88-94. |
[8] | 种铁,陈琦. 米拉贝隆治疗膀胱过度活动症的临床应用[J]. 山东大学学报 (医学版), 2018, 56(3): 6-11. |
[9] | 王殊,彭媛. 从2017年美国临床肿瘤学会大会报告看早期乳腺癌治疗加减法[J]. 山东大学学报 (医学版), 2018, 56(1): 17-21. |
[10] | 陈波,张磊. 2017年乳腺癌新辅助治疗进展[J]. 山东大学学报 (医学版), 2018, 56(1): 12-16. |
[11] | 卢晔,崔会芳,陈旭君,黄溢华,吴奕群,黄建隆,陈辉民,熊贤俊,陈明红. 冷冻技术在呼吸介入治疗中的应用进展及其并发症防治浅析[J]. 山东大学学报(医学版), 2017, 55(4): 19-22. |
[12] | 耿兴义, 张济, 贾堂宏, 向妮娟, 任瑞琦, 杨富强. 中东呼吸综合征最新研究进展[J]. 山东大学学报(医学版), 2014, 52(7): 106-108. |
[13] | 李宁, 邓红琼, 王翠兰. 进展性脑梗死患者血清Hs-CRP、SAA水平变化及意义[J]. 山东大学学报(医学版), 2014, 52(10): 45-48,60. |
[14] | 张济1,耿兴义1,曹若明1,杨国樑1,贾堂宏2,3. 球新型冠状病毒感染的研究进展[J]. 山东大学学报(医学版), 2013, 51(4): 108-112. |
[15] | 孙博睿,江立玉,马婷婷,杨其峰. 肉芽肿性小叶性乳腺炎诊治进展[J]. 山东大学学报(医学版), 2012, 50(7): 81-86. |
|